Temple-backed biotech firm aimed at knocking out HIV raises $60M

The company's co-founder is director of the neurosciences department and center for neurovirology at the Lewis Katz School of Medicine at Temple.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.